Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

10.71
Delayed Data
As of Dec 02
 +0.18 / +1.71%
Today’s Change
9.23
Today|||52-Week Range
38.73
-70.57%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close10.53
Today’s open10.51
Day’s range10.51 - 11.19
Volume235,806
Average volume (3 months)294,078
Market cap$306.8M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-119.15%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...+0.26+3.16%
SRNESorrento Therapeutic...-0.10-1.90%
PRTKParatek Pharmaceutic...+0.15+1.13%
ZGNXZogenix Inc+0.35+2.76%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts


Search for Jobs